Kelly Madden

Kelly Madden currently serves as Director at Travere Therapeutics, a position held since September 2024. Prior to this role, Madden was Senior Marketing Manager at Genentech from January 2022 to October 2024 and held the position of Director of Patient Services at Provention Bio from October 2020 to January 2022. Kelly's extensive experience at Genentech also includes roles as Product Marketing Manager and Strategy Lead for Ocrevus from December 2013 to October 2020. Other relevant experience includes a stint as Principal Account Manager at Genzyme Sanofi and various account management and customer support roles at WCG, Jingle Networks, and Timberlane Pediatrics. Kelly Madden holds a Bachelor of Science in Business from Saint Michael's College and studied abroad in French at the University of Paris I: Panthéon-Sorbonne.